GSK 299423

GSK 299423
Identifiers
ChemSpider 24751852 Y
Jmol-3D images Image 1
Properties
Molecular formula C25H27N5O2S
Molar mass 461.58 g mol−1
 Y (verify) (what is: Y/N?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

GSK 299423 or GlaxoSmithKline 299423 is an antibiotic chemical compound that has been identified as potentially effective in treating patients infected with bacteria expressing the New Delhi metallo-beta-lactamase. The antibiotic inhibits the enzyme topoisomerase, which bacteria need to replicate.[1][2][3]

No animal studies have been reported. No application has been made for human clinical trials.

References

  1. ^ Sten Stovall, "Glaxo:New Compound Offers Way To Fight Drug-Resistant Bacteria," The Wall Street Journal, August 4, 2010
  2. ^ Melly Alazraki, "GlaxoSmithKline Finds Compound That Could Help Fight 'Superbugs'" Daily Finance, August 6, 2010
  3. ^ Bax BD et al. (4 August 2010). "Type IIA topoisomerase inhibition by a new class of antibacterial agents". Nature 466 (7309): 935–40. doi:10.1038/nature09197. PMID 20686482.  (primary source)